Medpharm based in Guildford, close to Sinclair’s own corporate office is a specialist contract formulation and development company for topical drugs and new delivery systems. Terbinafine is marketed
3SBio plans to develop pegsiticase in China and will seek partnerships for development outside of China. Pegsiticase (Uricase-PEG 20) is a pegylated recombinant uricase derived from Candida utilis,
Following the agreement, US Farms is now set to release two new products in 2011 which will promote prostate health, support normal urination frequency and normal prostate size.
WomanCare Global said that both the products were developed by ICON in partnership with a trusted generic manufacturer following an extensive in-depth quality and technical assessment process undertaken
Biotage said that ChemMatrix is a patented 100% PEG resin from Matrix Innovation that offers substantial advantages over traditional PS and PEG based resins for solid phase peptide
The study results showed that lubiprostone was safe and well-tolerated. The long-term Phase III safety trial was an open-label, multi-centre study which enrolled 209 Japanese patients with a
Under the agreement, Adamis Pharma and Beximco Pharma plan to introduce four generic respiratory drug formulations in the US market over the next three years. The two companies
Cyclophosphamide is the active drug used in Revimmune therapy, Accentia‘s proprietary system-of-care being developed for the treatment of a broad range of autoimmune diseases. The agreement also grants
The article, published in International Journal of Pharmaceutics, entitled, ‘Enhanced in vitro Transbuccal Drug Delivery of Ondansetron HCl,’ highlights NexACT enhancers’ ability to significantly improve permeation of ondansetron,
The DESSOLVE I study is a prospective, open-label, non-randomized, single-arm study that is expected to enroll 30 patients at five clinical sites in Belgium, Australia and New Zealand.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.